Titan Medical Inc. (TMDI) – Business Wire
-
Titan Medical Announces Executive Departure
-
Titan Medical to Present at the H.C. Wainwright Global Investment Conference
-
Titan Medical Reports Financial Results for the First Quarter 2022
-
Titan Medical Announces Availability of Materials for the 2022 Annual and Special Meeting of Shareholders
-
Titan Medical Announces Purchase Order from Medtronic
-
Titan Medical to Issue First Quarter 2022 Financial Results on May 12, 2022
-
Titan Medical to Present at the Bloom Burton & Co. Healthcare Investor Conference
-
Titan Medical Reports Operating and Financial Results for the Fourth Quarter and Year End 2021
-
Titan Medical to Report Year End 2021 Financial Results on March 24, 2022
-
Titan Medical to Present at the Oppenheimer 32nd Annual Healthcare Conference
-
Titan Medical Expands Patent Portfolio to More Than 200 Patents and Applications and Clarifies Third-Party Licensing Strategy
-
Titan Medical Receives Final Milestone Payment and Retires Senior Secured Loan From Medtronic
-
Titan Medical Selects Benchmark to Manufacture Enos Robotic Single Access Surgical System
-
Titan Medical to Participate in H.C. Wainwright BioConnect 2022 Virtual Investor Conference
-
Titan Medical Completes Final Milestone Under Development Agreement with Medtronic
-
Titan Medical Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
Titan Medical Announces CEO Transition
-
Titan Medical Reports Third Quarter 2021 Financial Results
-
Titan Medical Announces Expansion of Surgeon Advisory Board
-
Titan Medical to Report Third Quarter 2021 Financial Results on November 11, 2021
-
Titan Medical Announces Completion of Pre-Clinical GLP Studies
-
Titan Medical to Participate in Upcoming Investor Conferences in September
-
Titan Medical to Participate in H.C. Wainwright Investor Conference
-
Titan Medical Reports Second Quarter 2021 Financial Results
-
Titan Medical to Report Second Quarter 2021 Financial Results on August 11, 2021
-
Titan Medical Announces Appointment of Tammy Carrea as Vice President of Quality and Regulatory Affairs
-
Titan Medical to Participate in Alliance Global Partners Virtual MedTech Summer Investor Conference
-
Titan Medical Announces Appointment of New Chief Financial Officer
-
Titan Medical Reports Voting Results From Annual and Special Meeting of Shareholders
-
Titan Medical to Present at Oppenheimer MedTech Summit Investor Conference
-
Titan Medical Reports First Quarter 2021 Financial Results and Provides Board Update
-
Titan Medical to Report First Quarter 2021 Financial Results May 17, 2021
-
Titan Medical Expands Senior Leadership Team
-
Titan Medical to Present at Bloom Burton & Co. Healthcare Investor Conference
-
Titan Medical to Participate in Upcoming Investor Conferences
-
Titan Medical Issues Corporate Update
-
Titan Medical to Present at H.C. Wainwright Global Life Sciences Conference
-
Titan Medical Announces Closing of US $23M Bought Deal Offering Including Full Exercise of Over-Allotment Option
-
Titan Medical Reports Year-End 2020 Financial Results
-
Titan Medical Announces Filing of Final Short Form Prospectus
-
Titan Medical Launches “Titan Living Labs” Showcasing a Behind-the-Scenes Look at Product Development
-
Titan Medical to Report Year-End 2020 Financial Results and Host Webcast on February 22, 2021
-
Titan Medical Announces Filing of Preliminary Short Form Prospectus
-
Titan Medical Announces Upsize to Previously Announced Bought Deal Offering
-
Titan Medical Announces Us $15 Million Bought Deal Offering
-
Titan Medical Announces Closing of US $11.5M Bought Deal Offering Including Full Exercise of Over-Allotment Option
-
Titan Medical Announces Filing of Final Short Form Prospectus
-
Titan Medical Announces Filing of Preliminary Short Form Prospectus
-
Titan Medical Announces US$10 Million Bought Deal Offering
-
Titan Medical Provides Regulatory Update
Back to TMDI Stock Lookup
